Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 703

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 703
---
350 shares of combined company common stock held by David J. Tweardy; and (v) 5,105 shares common stock issuable upon the exercise of stock options held by David J. Tweardy that are exercisable within 60 days of January 15, 2025. David J. Tweardy is the Trustee of

408

TABLE OF CONTENTS

the Benjamin John Tweardy 2020 Gift Trust, the Daniel James Tweardy 2020 Gift Trust and the Samuel David Tweardy 2020 Gift Trust.

(2)

Consists of (i) 1,169,097 shares of combined company common stock and (ii) 5,105 shares common stock issuable upon the exercise of stock options within 60 days of January 15, 2025.

(3)

Consists of (i) 1,072,055 shares of combined company common stock (including 120,023 Conversion Shares) held by Slate Path Master Fund LP; and (ii) 135,821 shares of combined company common stock (including 15,749 Conversion Shares) held by SPB Master Fund LP. Slate Path Capital LP, a Delaware limited partnership, is the investment manager of Slate Path Master Fund LP, a Cayman Islands exempted limited partnership, and SPB Master Fund LP, a Cayman Islands exempted limited partnership. David Greenspan is the managing member of Slate Path Capital GP LLC, a Delaware limited liability company and the general partner of Slate Path Capital LP. The address for Slate Path and Mr. Greenspan is 717 Fifth Avenue, 16th Floor, New York, NY 10022.

(4)

Consists of (i) 1,471,670 shares of combined company common stock held by Sporos Bioventures LLC; and (ii) 252,051 shares of combined company common stock held by Sporos Co-Invest T1 LLC. The board of managers of Sporos Bioventures LLC consists of Alex Cranberg, Peter Feinberg, Harold Levy, and Rachel Humphrey. The manager of Sporos Co-Invest T1 LLC is Sporos Bioventures, Inc. The board of directors of Sporos Bioventures, Inc. consists of Alex Cranberg. The address for Sporos is 3139 West Holcombe Blvd, Houston, TX 77025.

(5)

Consists of stock options exercisable within 60 days of January 15, 2025.

(6